Benjamin Edwards Inc’s Enzo Biochem, Inc. ENZ Stock Holding History

Benjamin Edwards Inc’s Portfolio ENZ Stock Details ENZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-300	Closed	–	–	1211
2024 Q2	$0	Hold	300	–	–	﹤0.01%	781
2024 Q1	$0	Hold	300	–	–	﹤0.01%	759
2023 Q4	$0	Hold	300	–	–	﹤0.01%	673
2023 Q3	$0	Hold	300	–	–	﹤0.01%	694
2023 Q2	$1K	Hold	300	–	–	﹤0.01%	666
2023 Q1	$1K	Hold	300	–	–	﹤0.01%	689
2022 Q4	$0	Hold	300	–	–	﹤0.01%	772
2022 Q3	$1K	Hold	300	–	–	﹤0.01%	704
2022 Q2	$1K	Hold	300	–	–	﹤0.01%	708
2022 Q1	$1K	Hold	300	–	–	﹤0.01%	687
2021 Q4	$1K	Hold	300	–	–	﹤0.01%	706
2021 Q3	$1K	Hold	300	–	–	﹤0.01%	533
2021 Q2	$1K	Hold	300	–	–	﹤0.01%	404
2021 Q1	$1K	Hold	300	–	–	﹤0.01%	373
2020 Q4	$1K	Hold	300	–	–	﹤0.01%	368
2020 Q3	$1K	Hold	300	–	–	﹤0.01%	352
2020 Q2	$1K	Hold	300	–	–	﹤0.01%	366
2020 Q1	$1K	Hold	300	–	–	﹤0.01%	359
2019 Q4	$1K	Hold	300	–	–	﹤0.01%	275
2019 Q3	$1K	Hold	300	–	–	﹤0.01%	293
2019 Q2	$1K	Hold	300	–	–	﹤0.01%	298
2019 Q1	$1K	Buy	+300	New	+$982	﹤0.01%	275

Other funds holding ENZ

HFA

Harbert Fund Advisors Birmingham, Alabama $3.03M AUM 40.55% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

WIM

Wittenberg Investment Management Carlisle, Massachusetts $269M AUM 28.17% 1-Year Est. Return

Benjamin Edwards Inc's ENZ Position: Q3 2024 in Review

Benjamin Edwards Inc sold out of Enzo Biochem, Inc. (ENZ) in Q3 2024, closing a stake of 300 shares.

Benjamin Edwards Inc first reported a position in ENZ in Q1 2019 and held it in 22 quarters. The position peaked at $1K in Q2 2023. 43 funds tracked by Wall St. Rank hold ENZ as of Q3 2024.

Benjamin Edwards Inc reported no remaining Enzo Biochem, Inc. position as of Q3 2024 after selling out during the quarter.
Benjamin Edwards Inc sold 300 Enzo Biochem, Inc. shares in Q3 2024.
Benjamin Edwards Inc first reported a position in Enzo Biochem, Inc. in Q1 2019 and held it in 22 quarters.
Benjamin Edwards Inc's Enzo Biochem, Inc. position peaked at $1K in Q2 2023.
43 funds tracked by Wall St. Rank held Enzo Biochem, Inc. as of Q3 2024.

Based on Benjamin Edwards Inc's 13F filing for Q3 2024, filed 14 Nov 2024.